✓
Open
19 Feb 2024
✓
Close
22 Feb 2024
3
Allotment
—
✓
Listing
Tue, Feb 27, 2024
Price Band
₹75 to ₹79
Issue Size
51,48,800 shares (agg. up to ₹41 Cr)
Lot Size
1,600 Shares
Listing Date
Tue, Feb 27, 2024
Latest GMP
₹35
Est. Gain
44.3%
✦ AI Insight
GMP Trend
27-02-2024₹35Est. ₹114+44.3%
26-02-2024₹35Est. ₹114+44.3%
25-02-2024₹40Est. ₹119+50.63%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 124.58x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|
| Assets | 112.49 | 97.94 | 68.58 |
| Total Income | 69.48 | 115.70 | 92.67 |
| Profit After Tax | 5.39 | 5.15 | 3.13 |
| NET Worth | 22.65 | 17.24 | 12.09 |
| Reserves and Surplus | 10.65 | 16.84 | 11.69 |
| Total Borrowing | 29.03 | 26.05 | 18.81 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Sunrest Lifescience Ltd. | SME | ₹10.85 Cr | ₹84 | 12.33 | ₹79.80 | -5.00% | ₹35.00 (-1.69%) |
| Mono Pharmacare Ltd. | SME | ₹14.84 Cr | ₹28 | null | ₹30.45 | +8.75% | ₹10.75 (+4.88%) |
| Shelter Pharma Ltd. | SME | ₹16.03 Cr | ₹42 | 5.62 | ₹41.96 | -0.10% | ₹26.00 (+1.96%) |
| Vilin Bio Med Ltd. | SME | ₹12.00 Cr | ₹30 | 24.59 | ₹28.50 | -5.00% | ₹42.25 (-4.52%) |
| Remus Pharmaceuticals Ltd. | SME | ₹47.69 Cr | ₹1229 | 21.09 | ₹1,796.80 | +46.20% | ₹737.40 (-0.29%) |
| Infinium Pharmachem Ltd. | SME | ₹25.25 Cr | ₹135 | 7.83 | ₹147.80 | +9.48% | ₹206.05 (-3.04%) |
| Sotac Pharmaceuticals Ltd. | SME | ₹33.30 Cr | ₹111 | 132.14 | ₹120.75 | +8.78% | ₹95.10 (-4.90%) |
| Innova Captab Ltd. | Mainboard | ₹570.00 Cr | ₹448 | 31.64 | ₹541.40 | +20.85% | ₹1,011.30 (+2.04%) |
| Blue Jet Healthcare Ltd. | Mainboard | ₹840.27 Cr | ₹346 | 37.49 | ₹413.40 | +19.48% | ₹588.15 (-1.65%) |
| Valiant Laboratories Ltd. | Mainboard | ₹152.46 Cr | ₹140 | 15.71 | ₹170.25 | +21.61% | ₹63.60 (-1.68%) |
| Concord Biotech Ltd. | Mainboard | ₹1,550.52 Cr | ₹741 | 32.29 | ₹942.80 | +27.23% | ₹1,346.00 (+0.23%) |
| Mankind Pharma Ltd. | Mainboard | ₹4,326.36 Cr | ₹1080 | 32.5 | ₹1,080.00 | +0.00% | ₹2,546.00 (-0.06%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of Machinery & Equipments for Setting up New Unit | 10.61 |
| 2 | Existing Manufacturing Block Upgradation | 2.11 |
| 3 | Working Capital Requirements | 14.40 |
| 4 | General Corporate Purposes | 8.84 |
| Total | 35.96 |
About Zenith Drugs IPO
Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs. The company adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification from a respected EuroUK certification body, demonstrating its commitment to quality. The product portfolio of the company includes ORS Powder; Liquid Orals; Ointments; Liquid Externals; and Capsules The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production. The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh. The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan , Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry. Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others. There are currently 89
Contact Details
Zenith Drugs Ltd. AddressK.No.72 / 5Village MuradpuraNA DepalpurIndore, Madhya Pradesh, 453001+91 8435501867info@zenithdrugs.comVisit Website